GNAI3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.524000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.010400E-01
Normal-vs-Stage2
7.321800E-01
Normal-vs-Stage3
2.595600E-01
Normal-vs-Stage4
2.575400E-01
Stage1-vs-Stage2
2.081400E-01
Stage1-vs-Stage3
9.452200E-01
Stage1-vs-Stage4
3.733800E-02
Stage2-vs-Stage3
2.620400E-01
Stage2-vs-Stage4
6.460300E-02
Stage3-vs-Stage4
3.744100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.329600E-01
Normal-vs-AfricanAmerican
9.923000E-01
Normal-vs-Asian
4.476200E-01
Caucasian-vs-AfricanAmerican
5.154800E-01
Caucasian-vs-Asian
5.480800E-01
AfricanAmerican-vs-Asian
3.668800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.545400E-01
Normal-vs-Female
7.982400E-01
Male-vs-Female
1.331760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.571400E-01
Normal-vs-Age(41-60Yrs)
8.622200E-01
Normal-vs-Age(61-80Yrs)
4.925600E-01
Normal-vs-Age(81-100Yrs)
4.091200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.647800E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.013200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.676000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.284500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.284200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.537200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.633200E-01
Normal-vs-Daily Drinker
5.863600E-01
Normal-vs-Weekly Drinker
4.578600E-01
Normal-vs-Occasional Drinker
8.374200E-01
Normal-vs-Social Drinker
7.751000E-01
Non Drinker-vs-Daily Drinker
6.424400E-01
Non Drinker-vs-Weekly Drinker
9.128400E-01
Non Drinker-vs-Occasional Drinker
3.265800E-02
Non Drinker-vs-Social Drinker
3.033400E-01
Daily Drinker-vs-Weekly Drinker
7.893400E-01
Daily Drinker-vs-Occasional Drinker
1.534370E-01
Daily Drinker-vs-Social Drinker
6.163000E-01
Weekly Drinker-vs-Occasional Drinker
1.086360E-01
Weekly Drinker-vs-Social Drinker
4.628600E-01
Occasional Drinker-vs-Social Drinker
3.911000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.763000E-01
Normal-vs-Grade 2
7.771200E-01
Normal-vs-Grade 3
7.714200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.38750000000065E-05
Grade 1-vs-Grade 3
7.003500E-04
Grade 1-vs-Grade 4
9.763000E-01
Grade 2-vs-Grade 3
8.920600E-01
Grade 2-vs-Grade 4
7.771200E-01
Grade 3-vs-Grade 4
7.714200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.229200E-01
Normal-vs-NonDiabetic
6.168600E-01
Diabetic-vs-NonDiabetic
5.621800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.895800E-01
Normal-vs-NoPancreatitis
6.241200E-01
Pancreatitis-vs-NoPancreatitis
8.652600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.708400E-01
Normal-vs-N1
7.916200E-01
N0-vs-N1
7.691500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.641600E-01
Normal-vs-TP53-NonMutant
2.200200E-01
TP53-Mutant-vs-TP53-NonMutant
2.11199999999856E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
